Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California Davis, Davis, CA 95817, USA.
Hepatology. 2013 Feb;57(2):555-65. doi: 10.1002/hep.26047. Epub 2013 Jan 10.
Hepatic methionine metabolism may play an essential role in regulating methylation status and liver injury in Wilson's disease (WD) through the inhibition of S-adenosylhomocysteine hydrolase (SAHH) by copper (Cu) and the consequent accumulation of S-adenosylhomocysteine (SAH). We studied the transcript levels of selected genes related to liver injury, levels of SAHH, SAH, DNA methyltransferases genes (Dnmt1, Dnmt3a, Dnmt3b), and global DNA methylation in the tx-j mouse (tx-j), an animal model of WD. Findings were compared to those in control C3H mice, and in response to Cu chelation by penicillamine (PCA) and dietary supplementation of the methyl donor betaine to modulate inflammatory and methylation status. Transcript levels of selected genes related to endoplasmic reticulum stress, lipid synthesis, and fatty acid oxidation were down-regulated at baseline in tx-j mice, further down-regulated in response to PCA, and showed little to no response to betaine. Hepatic Sahh transcript and protein levels were reduced in tx-j mice with consequent increase of SAH levels. Hepatic Cu accumulation was associated with inflammation, as indicated by histopathology and elevated serum alanine aminotransferase (ALT) and liver tumor necrosis factor alpha (Tnf-α) levels. Dnmt3b was down-regulated in tx-j mice together with global DNA hypomethylation. PCA treatment of tx-j mice reduced Tnf-α and ALT levels, betaine treatment increased S-adenosylmethionine and up-regulated Dnmt3b levels, and both treatments restored global DNA methylation levels.
Reduced hepatic Sahh expression was associated with increased liver SAH levels in the tx-j model of WD, with consequent global DNA hypomethylation. Increased global DNA methylation was achieved by reducing inflammation by Cu chelation or by providing methyl groups. We propose that increased SAH levels and inflammation affect widespread epigenetic regulation of gene expression in WD.
通过铜(Cu)抑制 S-腺苷同型半胱氨酸水解酶(SAHH),导致 S-腺苷同型半胱氨酸(SAH)积累,肝蛋氨酸代谢可能在威尔逊病(WD)中通过调节甲基化状态和肝损伤中发挥重要作用。我们研究了与肝损伤相关的选定基因的转录水平、SAHH、SAH、DNA 甲基转移酶基因(Dnmt1、Dnmt3a、Dnmt3b)的水平以及 WD 动物模型 tx-j 小鼠的全基因组 DNA 甲基化。将结果与对照 C3H 小鼠进行比较,并比较了铜螯合剂青霉胺(PCA)和甲基供体甜菜碱对调节炎症和甲基化状态的反应。在 tx-j 小鼠中,与内质网应激、脂质合成和脂肪酸氧化相关的选定基因的转录水平在基线时下调,对 PCA 的反应进一步下调,对甜菜碱的反应几乎没有。tx-j 小鼠肝 Sahh 转录和蛋白水平降低,导致 SAH 水平升高。肝 Cu 积累与炎症相关,组织病理学和血清丙氨酸氨基转移酶(ALT)和肝肿瘤坏死因子α(Tnf-α)水平升高表明这一点。tx-j 小鼠中 Dnmt3b 下调,同时全基因组 DNA 低甲基化。tx-j 小鼠 PCA 治疗降低了 Tnf-α 和 ALT 水平,甜菜碱治疗增加了 S-腺苷甲硫氨酸并上调了 Dnmt3b 水平,两种治疗均恢复了全基因组 DNA 甲基化水平。
WD 的 tx-j 模型中,肝 Sahh 表达减少与肝 SAH 水平升高相关,导致全基因组 DNA 低甲基化。通过减少炎症(通过 Cu 螯合)或提供甲基来增加全基因组 DNA 甲基化。我们提出,SAH 水平升高和炎症影响 WD 中广泛的基因表达表观遗传调控。